English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

US: Digital Development achieves first State sales approval for MiteXstream™, a biopesticide targeting cannabis grows in Nevadaqrcode

Mar. 25, 2021

Favorites Print
Forward
Mar. 25, 2021

Follow

Digital Development Partners, Inc. (OTC PINK:DGDM) ("DGDM" or the "Company"), manufacturer of MiteXstream™ biopesticide and Grizzly Creek Naturals CBD products, announces that the State of Nevada has approved sales of MiteXstream™ (Geraniol and Citronellol), the Company's disruptive first-to-market, EPA-certified biopesticide targeted initially at cannabis grows experiencing mold, mildew and spider mite issues. Applications in four other Western states remain pending, with approval expected in approximately 2 to 4 weeks, and applications for the next set of states, including California and New Jersey, are expected to be submitted in the near future.


Fabian Deneault, President of Digital Development, stated, "This marks the first state in which we are cleared to sell MiteXstream™, and growers in Nevada can now prevent and eliminate spider mites and molds and mildews with an extremely effective biopesticide that can be applied through the day of harvest, while still passing state pesticide testing standards." Continuing, Mr. Deneault added, "The economic impact for the good to growers delivered by MiteXstream™ is exceptional."


ABOUT MITEXSTREAM


Plant-based MiteXstream™ treats spider mites and other pests and outbreaks of mold and mildew through the day of harvest without state testing failures - that unique feature is MiteXstream™'s disruptive competitive advantage. In fact, the Company continues to believe that, due to MiteXstream™'s efficacy, the Company will become a Major Cannabis Innovator in the minds of industry players. MiteXstream™ provides a superior cost-benefit on valuable crops throughout the entire grow cycle.


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox